<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A"><gtr:id>5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A</gtr:id><gtr:name>Aston University</gtr:name><gtr:address><gtr:line1>Aston Triangle</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:postCode>B4 7ET</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77C66895-4D42-4105-A4C9-46E246CA4A4B"><gtr:id>77C66895-4D42-4105-A4C9-46E246CA4A4B</gtr:id><gtr:name>University of Auckland</gtr:name><gtr:address><gtr:line1>The University of Auckland</gtr:line1><gtr:line2>Private Bag 92601</gtr:line2><gtr:line3>Symonds Street</gtr:line3><gtr:line4>Auckland</gtr:line4><gtr:postCode>1150</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>New Zealand</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ED6A6B32-663C-4A62-A33B-2C6A68E2E102"><gtr:id>ED6A6B32-663C-4A62-A33B-2C6A68E2E102</gtr:id><gtr:name>University of Essex</gtr:name><gtr:address><gtr:line1>Wivenhoe Park</gtr:line1><gtr:line4>Colchester</gtr:line4><gtr:line5>Essex</gtr:line5><gtr:postCode>CO4 3SQ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A"><gtr:id>5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A</gtr:id><gtr:name>Aston University</gtr:name><gtr:department>Sch of Life and Health Sciences</gtr:department><gtr:address><gtr:line1>Aston Triangle</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:postCode>B4 7ET</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A"><gtr:id>5BFB9036-9D16-4AB9-A9EF-097BB6FBD69A</gtr:id><gtr:name>Aston University</gtr:name><gtr:address><gtr:line1>Aston Triangle</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:postCode>B4 7ET</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5E72F91-30E2-45E6-8D19-EDC197FF970A"><gtr:id>A5E72F91-30E2-45E6-8D19-EDC197FF970A</gtr:id><gtr:name>Monash University</gtr:name><gtr:address><gtr:line1>Monash University</gtr:line1><gtr:line2>Level 1, Chancellery Building D</gtr:line2><gtr:line3>26 Sports Walk, Wellington Road</gtr:line3><gtr:postCode>3800</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77C66895-4D42-4105-A4C9-46E246CA4A4B"><gtr:id>77C66895-4D42-4105-A4C9-46E246CA4A4B</gtr:id><gtr:name>University of Auckland</gtr:name><gtr:address><gtr:line1>The University of Auckland</gtr:line1><gtr:line2>Private Bag 92601</gtr:line2><gtr:line3>Symonds Street</gtr:line3><gtr:line4>Auckland</gtr:line4><gtr:postCode>1150</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>New Zealand</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ED6A6B32-663C-4A62-A33B-2C6A68E2E102"><gtr:id>ED6A6B32-663C-4A62-A33B-2C6A68E2E102</gtr:id><gtr:name>University of Essex</gtr:name><gtr:address><gtr:line1>Wivenhoe Park</gtr:line1><gtr:line4>Colchester</gtr:line4><gtr:line5>Essex</gtr:line5><gtr:postCode>CO4 3SQ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5E45B241-C5A8-4932-9EC8-35545ED598EC"><gtr:id>5E45B241-C5A8-4932-9EC8-35545ED598EC</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Roy</gtr:otherNames><gtr:surname>Poyner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/938B0269-F28D-45D8-B660-22A0CB6254DF"><gtr:id>938B0269-F28D-45D8-B660-22A0CB6254DF</gtr:id><gtr:firstName>Roslyn</gtr:firstName><gtr:surname>Bill</gtr:surname><gtr:orcidId>0000-0003-1331-0852</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FI019960%2F1"><gtr:id>C9BDE64D-C6E0-43CE-AD47-80E2D3183D0E</gtr:id><gtr:title>The Use Of Novel Polymer-Lipid Nanoparticles To Study G-Protein-Coupled Receptor Activation And Dynamics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/I019960/1</gtr:grantReference><gtr:abstractText>Most chemical messengers in the body, work through proteins on the cell surface known as receptors. The biggest class of receptors is the G-protein-coupled receptor (GPCRs) family, which are important for cell signalling and as drug targets. GPCRs are thus of enormous interest, both in terms of basic biology and also for commercial exploitation by the pharmaceutical industry. Understanding how GPCRs work at the molecular level is fundamentally important and is one of the 'big questions' in biology today. For a few receptors we have a crystal structure showing their 3-dimensional shape when bound to a 'blocking drug'. This has deepened our understanding of receptor architecture which should aid future drug discovery. However, it is clear that GPCRs are very flexible proteins that change their shape on binding hormones and drugs, whereas the crystal structures provide snap-shots of a single conformation, usually of the non-signalling receptor. To fully understand GPCRs, we need to understand how they change their shape during signalling. This is also important for 'allosteric' agents that bind to a different part of the receptor to the natural hormone to modify receptor activity. This opens the way to a whole new class of drugs. In this application we describe a new approach to understanding GPCRs. We have found a novel way to make large quantities of natural GPCRs 'solubilised' within very small particles of their membrane environment without the need for detergent. Previously, there has been an absolute requirement for detergent to solubilise receptors. This formed a major barrier to progress in this field as its presence disrupted the normal properties and shape of the receptor, de-stabilising the protein. For the first time anywhere, we can now circumvent the detergent barrier to progress. This important advance opens up the prospect of applying powerful biophysical techniques to provide detailed information on how GPCRs dynamically change their shape in response to drugs of different classes. The project brings together four scientists from the Universities of Birmingham and Aston, with complementary skills to exploit our new technologies. We will study the adenosine A2a receptor (A2aR) as an example of the GPCR family. This is a well-characterised receptor with a large literature, defined drugs, useful tools and importantly it is one of the few receptors for which there is an atomic level crystal structure. In addition, our industrial collaborators Heptares Therapeutics will provide A2aRs constrained into functionally-defined shapes (conformations) which will be a great help to us. Finally we have a formal collaboration with an experienced computational chemist at Essex University who will construct molecular models and dynamic simulations of different functional states of the receptor based on our experimental data. We are ahead of the field and our pilot data show that we have the capability at this very moment to produce very large amounts of A2aR by growing them in a yeast and to rapidly 'solubilise' active receptors in their natural state in a styrene maleic acid lipid particle (SMALP). We will engineer A2aR so that 'reporter groups', including fluorescent groups, can be introduced at defined locations in the receptor architecture. We can then study A2aR-SMALP by a range of techniques. For example, fluorescence can tell us about the changes in the environment around important parts of the receptor when drugs bind. A related technique can also be used to provide a molecular ruler that allows us to calculate the distance between two parts of the receptor to determine how it changes on binding drugs of different signalling capability or in conformationally-constrained A2aRs provided by Heptares Therapeutics. Overall, this project will provide insight into the changes of shape that underlie GPCR activation and may aid rational drug design in the future.</gtr:abstractText><gtr:technicalSummary>G-protein-coupled receptors (GPCRs) are the largest class of receptors and the largest target for prescription drugs. The processes underlying GPCR activation at the molecular level remain poorly understood. Recent crystal structures have provided static snap-shots of a few of these highly flexible proteins. A full understanding of GPCR signalling requires knowledge of the various states adopted by the receptor in response to ligands of differing efficacy (full agonist, inverse agonist) and the dynamics of the inter-conversions of these states. A formidable barrier to progress in this field is that the detergents required to solubilise GPCRs de-stabilise the receptors and disrupt conformational states. We have developed novel technologies to 'solubilise' GPCRs in a styrene maleic acid lipid particle (SMALP), without detergent, preserving native conformations and enabling powerful biophysical analyses - a world first. We aim to exploit this advantage to study the adenosine A2a receptor (A2aR) a GPCR. Conformationally stabilised receptors (StaRs) provided by Heptares Therapeutics will be an asset and the published antagonist-A2aR crystal structure provides a defined structure for modelling A2aR conformational changes. We will: 1) Enable A2aR for site-specific incorporation of reporters to allow downstream biophysical analyses. 2) Characterise constructs in HEK293T cells, which will then be over-expressed in P. pastoris, solubilised by spontaneous embedding into SMALPs and purified. 3) Use a battery of biophysical techniques to: i) Define the changes in A2aR conformation underlying activation and characterise the dynamics of inter-conversions. ii) Identify differences in conformation when the receptor is occupied by ligands of different efficacy (full agonist, partial agonist, inverse agonist). iii) Define A2aR conformation modifications induced by allosteric ligands. iv) Use constraints from biophysical data to build unified structural models of GPCR activation.</gtr:technicalSummary><gtr:potentialImpactText>The research described in this proposal will increase understanding of the molecular processes underlying GPCR activation and how these processes are initiated or blocked by the receptor binding different classes of ligand (agonist/antagonist/inverse agonist/allosteric modulator). This will have a significant impact in the field of cell signalling in academia and also within the Pharmaceutical Industry. The insights provided may lead to rational drug design in the future producing drugs which are better able to activate or block discrete aspects of receptor signalling. This would lead to improved medicines which would increase the quality of life. Our research is directly relevant to the Pharmaceutical Industry in the UK as is evident from the 'Letter of Support and Collaboration' from our industrial collaborator Heptares Therapeutics Ltd (attached). Any advance we make would be exploited by Pharma companies. Our technologies may be applicable to studying other membrane proteins thereby extending the impact of our research beyond cell signalling. Two PDRAs will be trained in a wide range of multidisiplinary skills which will be an asset to their career development and to subsequent employers.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>303301</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Monash University</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>SMALPing of calcitonin receptor</gtr:description><gtr:id>CCE512D6-BFA0-4992-8BB5-59EACB7B82EB</gtr:id><gtr:impact>Production of the purified calcitonin receptor for structural studies</gtr:impact><gtr:outcomeId>56420e2f82de09.24027660-1</gtr:outcomeId><gtr:partnerContribution>Provision of a cell line expressing the calcitonin receptor and a student to do the experimental work</gtr:partnerContribution><gtr:piContribution>We have supplied reagents and provided training for a research student to purify the calcitonin receptor using SMALPs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Dr Nick Holliday, Nottingham University</gtr:description><gtr:id>FCC3C5B7-548E-4F32-82BB-DB5A51367CD7</gtr:id><gtr:outcomeId>b95fe61eb95fe632-1</gtr:outcomeId><gtr:piContribution>Measurement of beta-arrestin interactions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Scripps Research Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Interaction with Schultz Group, USA</gtr:description><gtr:id>C0B35123-5990-4F87-B8B3-AE7C9566EDC2</gtr:id><gtr:impact>This opened the way to us using unnatural amino acid mutagenesis in eukaryotic expression systems</gtr:impact><gtr:outcomeId>b96362d0b96362e4-1</gtr:outcomeId><gtr:partnerContribution>We introduced unnatural amino acids into the A2a receptor expressed in yeast</gtr:partnerContribution><gtr:piContribution>Interaction with group and transfer of materials for unnatural amino acid incorporation</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Essex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Professor Chris Reynolds, University of Essex</gtr:description><gtr:id>17C4C98E-8CD5-4646-8DCD-BAB95032295C</gtr:id><gtr:outcomeId>b95fe4e8b95fe4fc-1</gtr:outcomeId><gtr:piContribution>A collaborator at Essex University is assisting us with molecular modelling of the A2a and M1 receptors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCB Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCB Celltech</gtr:department><gtr:description>Collaboration with UCB</gtr:description><gtr:id>37D43607-11F8-4370-ABEE-6961AC3DD808</gtr:id><gtr:impact>This lead to an application for a new project grant to the BBSRC and also resulted in the award of a university awarded PhD studentship.</gtr:impact><gtr:outcomeId>56c303f26bf914.59039778-1</gtr:outcomeId><gtr:partnerContribution>UCB are currently using our material to produce antibodies</gtr:partnerContribution><gtr:piContribution>We have supplied SMALP-solubilised GPCRs for antibody production; we are currently expanding this to RAMP-receptor complexes</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Using SMALPs for mass-spectroscopy analysis of GPCRs</gtr:description><gtr:id>EC30514D-4C82-449D-8A93-B7DDC7D5F6BF</gtr:id><gtr:impact>Grant applications submitted as follows:

Royal Society of New Zealand Marsden Fund, Hay, Robinson and Wheatley, 15-UOA-248, $870,000 NZD (unfunded)
University of Auckland Faculty Research Development Fund $160,000 (awarded)
Human Frontiers of Science Programme, Hay, Robinson and Wheatley, RGP0022/2016, $900,000 USD (application under assessment)</gtr:impact><gtr:outcomeId>56420d193b9633.38772467-2</gtr:outcomeId><gtr:partnerContribution>Analysis of receptor by mass-spec</gtr:partnerContribution><gtr:piContribution>We SMALPed the adenosine 2a and calcitonin receptors to allow them to be analysed by mass-spectroscopy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Aston University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life and Health Sciences</gtr:department><gtr:description>collaboration with Dr Alice Rothnie</gtr:description><gtr:id>DDDD0E07-8E9B-456E-8DAD-235FC01CE650</gtr:id><gtr:impact>Paper pulished in Biochemicl Journal</gtr:impact><gtr:outcomeId>545cef4f650a52.77266820-1</gtr:outcomeId><gtr:partnerContribution>Applying SMALP technology to ABC transporters</gtr:partnerContribution><gtr:piContribution>Providing SMALP technology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Mass spectroscopy of GPCRs</gtr:description><gtr:id>FD0F78C1-2184-40F8-A7AF-81C7D9A6C8F1</gtr:id><gtr:impact>This is an academic collaboration; we hope it will lead to new papers</gtr:impact><gtr:outcomeId>56c304dbe95f56.69017648-1</gtr:outcomeId><gtr:partnerContribution>The partners are analysing the GPCRs by mass spectroscopy</gtr:partnerContribution><gtr:piContribution>We have supplied purified GPCRs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Collaboration with Dr Ed Hulme</gtr:description><gtr:id>661F1C89-1AB6-47B1-B974-9E67359FD30B</gtr:id><gtr:outcomeId>b95fe736b95fe74a-1</gtr:outcomeId><gtr:piContribution>Collaboration on muscarinic receptor with NIMR, London</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Auckland</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:department>School of Biological Sciences</gtr:department><gtr:description>Using SMALPs for mass-spectroscopy analysis of GPCRs</gtr:description><gtr:id>4F68E375-F8ED-4AD7-9809-A2E2BF9A23EB</gtr:id><gtr:impact>Grant applications submitted as follows:

Royal Society of New Zealand Marsden Fund, Hay, Robinson and Wheatley, 15-UOA-248, $870,000 NZD (unfunded)
University of Auckland Faculty Research Development Fund $160,000 (awarded)
Human Frontiers of Science Programme, Hay, Robinson and Wheatley, RGP0022/2016, $900,000 USD (application under assessment)</gtr:impact><gtr:outcomeId>56420d193b9633.38772467-1</gtr:outcomeId><gtr:partnerContribution>Analysis of receptor by mass-spec</gtr:partnerContribution><gtr:piContribution>We SMALPed the adenosine 2a and calcitonin receptors to allow them to be analysed by mass-spectroscopy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>German Research School for Simulation Sciences, Julich, Germany</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>60DBB62E-FD54-4839-B34A-5D0E3F42A84F</gtr:id><gtr:impact>Questions and discussion after talk

Talk lead to discussions with molecular modellers that are continuing</gtr:impact><gtr:outcomeId>545c9293248587.16331911</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Moving molecules</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A4771260-9ACC-4A5C-8AE0-C0350B78477A</gtr:id><gtr:impact>Article for community newsletter describing the BBSRC funded project The newsletter is circulated around the villages of Highley, Billingsley, Chelmarsh, Deuxhill and Glazeley, my home communities Article for newsletter

Around 5 people commented that they had found the article interesting</gtr:impact><gtr:outcomeId>r-8162907518.5981650cc352cc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University of Nottingham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1F92EE3A-105B-463C-8E93-BF65E9670F92</gtr:id><gtr:impact>Questions and discussion after talk

This has helped a current collaboration with colleagues at Nottingham on the use of SMALPs</gtr:impact><gtr:outcomeId>545c93200f6a29.42035392</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>That Eureka Moment</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>998934DE-1F30-4394-AA55-47924687D430</gtr:id><gtr:impact>Article in community newsletter describing progress on the grant Follow-on from Moving Molecules

Several individuals commented on reading the article and how it had given them a better insight into the scientific process</gtr:impact><gtr:outcomeId>r-5426990841.9130290cc41a2c</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New ways of looking at GPCRs</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>63107710-1CEE-4C73-B360-C6D3CF84F592</gtr:id><gtr:impact>Project website

This has lead to several enquiries for PhD places</gtr:impact><gtr:outcomeId>r-3326279067.73824170cc34fc0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.aston.ac.uk/lhs/staff/az-index/poynerdr/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biomedical Research Centre, Sheffield Hallam University</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CA6A33F7-F697-4674-ABF4-D159A82A85BD</gtr:id><gtr:impact>Questions and discussion after the talk

The talk increased awareness of protein isolatin and purification methods amongst PhD students and undergraduates</gtr:impact><gtr:outcomeId>545c95111d4178.17596401</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PEGS Europe Summit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>52F62376-8E1C-41D1-A1B9-8DF2997D2E09</gtr:id><gtr:impact>This was the keynote presentation to in excess of 100 delegates at a conference about optimising protein expression and purification

This raised the profile of our work on SMALPs to a international audience</gtr:impact><gtr:outcomeId>544a35e2c78964.78258240</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Medical University of Vienna, Austria</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5A9FF9F2-D577-4A04-BE53-0746B44A3E8B</gtr:id><gtr:impact>Questions and discussions after talk

The talk increased awareness of the use of SMALPs</gtr:impact><gtr:outcomeId>545c93c75326f0.59399753</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Incorporation of unnatural amino acids into recombinant human adenosine-2a receptor produced in Pichia pastoris.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C5774A8D-1D9B-475A-80EF-851C8905DACC</gtr:id><gtr:impact>Poster presented at 7th Conference on Recombinant Protein Production (RPP), Germany, 6th-8th March 2013

This resulted in enquiries about placements in the laboratory</gtr:impact><gtr:outcomeId>r-9793055979.3422530ce3159e</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at 2016 SMALP users meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>81EDD77B-57F2-4FD7-8AF3-9BF679AA3DA0</gtr:id><gtr:impact>This was a 20 minute talk on the use of SMALPs for solubilising GPCRs</gtr:impact><gtr:outcomeId>56c30a1a9005b6.61621792</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Receptive Collaboration</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>68343778-D89F-4848-A629-EFD019E62BD4</gtr:id><gtr:impact>Article in International Innovation, November 2013, 113-115 One article

We have been approached for further articles</gtr:impact><gtr:outcomeId>r-3510791075.89162060cdc1e4c</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Australian Peptide Society, Penang, Malaysia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9556F798-01C6-4245-ABD9-7B07190B4CDC</gtr:id><gtr:impact>Questions and discussion after the talk

The talk increased awareness of the use of SMALPs</gtr:impact><gtr:outcomeId>545c9455e10813.82126049</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>How do drugs work</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F742CC6A-FA30-450B-AF6A-46BE178EF596</gtr:id><gtr:impact>Poster for village fete Poster

The poster generated much interest at the fete</gtr:impact><gtr:outcomeId>r-2442628994.9963140ce1c7c0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>School of Life and Health Sciences</gtr:department><gtr:description>Internal PhD studentship</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Aston University</gtr:fundingOrg><gtr:id>990DE84D-3F1F-40E1-94E4-0031FB2F529F</gtr:id><gtr:outcomeId>58a1988abea301.14329102</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>125520</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomarkers of the ageing tear film</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K013319/1</gtr:fundingRef><gtr:id>136BD4BD-0D00-4F3D-BEBE-62E92F46E71E</gtr:id><gtr:outcomeId>5ee590a45ee590b8</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>125520</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Engineering yeast for GPCR expression and functional studies</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>A71BB5E7-8753-4772-98FF-D52081BDF4AD</gtr:id><gtr:outcomeId>5ee6052a5ee60548</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Vacation Scholarship</gtr:department><gtr:description>Wellcome Trust Vacation Studentship</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>74DA587C-3479-4901-8AE0-CAE674D4C1F3</gtr:id><gtr:outcomeId>58a182f1b04717.03808521</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The findings have so far been reported in the magazine International Innovations, which is widely read by EU policy makers. Our work also needs to be seen in the wider context of the growth of use of SMALPs as agents to study commercially important membrane proteins; by demonstrating that they can be used to isolate G-protein coupled receptors (the largest target for therapeutic drugs), our results will be important for more efficient and effective drug discovery. To this end, we are presenting our results to the wider scientific community via papers and posters, as described elsewhere. We are currently working with a pharmaceutical company to use SMALP-solubilised GPCRs to produce new antibodies.</gtr:description><gtr:id>8FD3757D-EC9B-4F40-8501-6DBA0843644B</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>544a2e821bc461.24593427</gtr:outcomeId><gtr:sector>Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have now used our technology to isolate 2 different GPCRS from yeast, bacteria and mammalian cells. These receptors have been purified to homogeneity. We have further characterised one of these biophysically, to understand how drugs change the shape of the protein; this knowledge will be essential in designing improved drugs for the future.



We have used unnatural amino acid mutagenesis to introduce fluorescent reporters into our GPCRs. These are tools to measure the shape of the receptor. We have been able to use these to detect changes to the GPCRs when we add drugs.</gtr:description><gtr:exploitationPathways>The research can be used to design new classes of drugs and antibodies. This research is of interest to the pharmaceutical industry</gtr:exploitationPathways><gtr:id>0091F58C-A8D3-4B64-BF1D-7D75827F463B</gtr:id><gtr:outcomeId>r-1694817367.656917677829c92</gtr:outcomeId><gtr:sectors><gtr:sector>Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.aston.ac.uk/lhs/staff/az-index/poynerdr/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Our work has shown how it is possible to purify membrane proteins without detergents, by means of SMALPs</gtr:description><gtr:id>7586CFC9-58EE-4F74-8798-592B12BFCF2B</gtr:id><gtr:impact>This has resulted in colleagues at both Aston and Birmingham universities publishing papers using the technology</gtr:impact><gtr:outcomeId>544a3822035527.40941384</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Use of SMALPs</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3FF80C77-4FB1-4D19-82D3-D2B7F106C2E1</gtr:id><gtr:title>Functional recombinant protein is present in the pre-induction phases of Pichia pastoris cultures when grown in bioreactors, but not shake-flasks.</gtr:title><gtr:parentPublicationTitle>Microbial cell factories</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f47e95f70e70409d028c26146696bb9"><gtr:id>7f47e95f70e70409d028c26146696bb9</gtr:id><gtr:otherNames>Bawa Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2859</gtr:issn><gtr:outcomeId>544f6ce7026991.45163378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADFAC1A1-60E6-4D3B-AF23-33CC22B89367</gtr:id><gtr:title>The synthesis of recombinant membrane proteins in yeast for structural studies.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10481dbc1de2c4fcc925e281ef441dd1"><gtr:id>10481dbc1de2c4fcc925e281ef441dd1</gtr:id><gtr:otherNames>Routledge SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>585d74abd92e61.24153323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46C9CD9D-B2B3-4279-832C-3A272CBC0A77</gtr:id><gtr:title>Structural Determinants of Oligomerization of the Aquaporin-4 Channel.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57413c257793bb820c766b64bec831c2"><gtr:id>57413c257793bb820c766b64bec831c2</gtr:id><gtr:otherNames>Kitchen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>585d72614b82e9.70261367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ADF636A-F26B-4058-A6A2-939D1482A0DF</gtr:id><gtr:title>Beyond water homeostasis: Diverse functional roles of mammalian aquaporins.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57413c257793bb820c766b64bec831c2"><gtr:id>57413c257793bb820c766b64bec831c2</gtr:id><gtr:otherNames>Kitchen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>585d342f1372c5.54889966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5E132A6-F2F9-4FEA-87DE-6AEC7A3DEE69</gtr:id><gtr:title>Hijacked then lost in translation: the plight of the recombinant host cell in membrane protein structural biology projects.</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/affc477b16c011ace6a096118cb529cf"><gtr:id>affc477b16c011ace6a096118cb529cf</gtr:id><gtr:otherNames>Bill RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn><gtr:outcomeId>5675e5bf04720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F47B3399-5D97-46C8-83CA-3C9840403DAE</gtr:id><gtr:title>Structural analysis of a nanoparticle containing a lipid bilayer used for detergent-free extraction of membrane proteins</gtr:title><gtr:parentPublicationTitle>Nano Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b08d2b7f9fc00bcd87fca83ab5372507"><gtr:id>b08d2b7f9fc00bcd87fca83ab5372507</gtr:id><gtr:otherNames>Jamshad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>doi_55f94d94d8035293</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D14541D-731D-446D-8DB5-939564B47AFE</gtr:id><gtr:title>Detergent-Free Solubilisation of the Adenosine 2a Receptor and the Calcitonin Receptor Using Styrene Maleic Acid Lipid Particles (SMALPs)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b90e832242c79ffd093fc09ccc05b2e8"><gtr:id>b90e832242c79ffd093fc09ccc05b2e8</gtr:id><gtr:otherNames>Charlton J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56c301f4b2fc62.72467657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ECC4120-9393-407D-93A7-9CF706069CE9</gtr:id><gtr:title>Beyond de-foaming: the effects of antifoams on bioprocess productivity.</gtr:title><gtr:parentPublicationTitle>Computational and structural biotechnology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10481dbc1de2c4fcc925e281ef441dd1"><gtr:id>10481dbc1de2c4fcc925e281ef441dd1</gtr:id><gtr:otherNames>Routledge SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2001-0370</gtr:issn><gtr:outcomeId>doi_53d08d08df3343b6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B3DCDA7-3A1A-4B95-B715-BEEE1560B63B</gtr:id><gtr:title>G-protein coupled receptor solubilization and purification for biophysical analysis and functional studies, in the total absence of detergent.</gtr:title><gtr:parentPublicationTitle>Bioscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b08d2b7f9fc00bcd87fca83ab5372507"><gtr:id>b08d2b7f9fc00bcd87fca83ab5372507</gtr:id><gtr:otherNames>Jamshad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0144-8463</gtr:issn><gtr:outcomeId>5675e0260358f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>346876BD-942D-45B3-B500-4043469240B6</gtr:id><gtr:title>Constitutively-stressed yeast strains are high-yielding for recombinant Fps1: implications for the translational regulation of an aquaporin.</gtr:title><gtr:parentPublicationTitle>Microbial cell factories</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c4aea63422af0917bb6295fc5305a9e"><gtr:id>5c4aea63422af0917bb6295fc5305a9e</gtr:id><gtr:otherNames>Cartwright SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1475-2859</gtr:issn><gtr:outcomeId>5a2fceab573965.28769718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A02EE115-F9EF-46A7-9B25-063B6E9DB86A</gtr:id><gtr:title>Antifoams: the overlooked additive?</gtr:title><gtr:parentPublicationTitle>Pharmaceutical Bioprocessing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0ba00ccab0b2b0472ed5828854dc315"><gtr:id>b0ba00ccab0b2b0472ed5828854dc315</gtr:id><gtr:otherNames>Routledge S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>544a33735e9127.96181505</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2BE6EDA-1E42-4203-B344-93E2704B519B</gtr:id><gtr:title>The effect of antifoam addition on protein production yields.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10481dbc1de2c4fcc925e281ef441dd1"><gtr:id>10481dbc1de2c4fcc925e281ef441dd1</gtr:id><gtr:otherNames>Routledge SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-61779-769-9</gtr:isbn><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_53cc03fc03f027023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3044F0A-0945-4A55-9314-3C23B1861C03</gtr:id><gtr:title>Characterisation of the Adenosine 2a Receptor Solubilised by Styrene Maleic Acid Lipid Particles (SMALPs)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10481dbc1de2c4fcc925e281ef441dd1"><gtr:id>10481dbc1de2c4fcc925e281ef441dd1</gtr:id><gtr:otherNames>Routledge SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56c302aba70125.90292529</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDA6D2DB-AF8B-4168-8E3E-5009023D0565</gtr:id><gtr:title>GPCR-styrene maleic acid lipid particles (GPCR-SMALPs): their nature and potential.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025d16444abf7d47540a595bcb025912"><gtr:id>025d16444abf7d47540a595bcb025912</gtr:id><gtr:otherNames>Wheatley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>585d707f79fd05.48652103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62196B86-AA4B-4C0C-AAD5-45B39E2C2C4B</gtr:id><gtr:title>Lifting the lid on GPCRs: the role of extracellular loops.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025d16444abf7d47540a595bcb025912"><gtr:id>025d16444abf7d47540a595bcb025912</gtr:id><gtr:otherNames>Wheatley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_53cc03bc03b828f7e</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/I019960/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>